Prestizia Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 3

Employees

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 1

Prestizia General Information

Description

Provider of biotechnology research and development services. The company engages in developing novel diagnostic assays for viral infections and human malignancies based on microRNA expression.

Contact Information

Website
www.prestizia.fr
Ownership Status
Acquired/Merged
Financing Status
Private Equity-Backed
Corporate Office
  • 5 Rue de la Baume
  • 75008 Paris
  • France
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Acquirer
TheraDiag
Vertical(s)
Life Sciences
Corporate Office
  • 5 Rue de la Baume
  • 75008 Paris
  • France

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Prestizia Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Prestizia‘s full profile, request access.

Request a free trial

Prestizia Patents

  • 7

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 1

    Pending

  • Expiring in next 12 mo

Prestizia Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3211096-A1 Combination of mirnas allowing the prediction of the clinical evolution of rectal cancer Inactive 26-Feb-2016
EP-3008208-A1 Methods for detecting an infectious agent Inactive 14-Jun-2013
EP-2813578-A1 Methods for detecting an infectious agent, in particular hiv1, using long noncoding rna Inactive 14-Jun-2013
EP-2828410-A1 Methods for determining the tropism and receptor usage of a virus, in particular hiv, in body samples taken from the circulation Inactive 19-Mar-2012
JP-2015512249-A Method for determining affinity and receptor usage of viruses, especially hiv, in body samples taken from the circulation Pending 19-Mar-2012 C12Q1/6883
To view Prestizia’s complete patent history, request access »

Prestizia Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Prestizia Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Prestizia‘s full profile, request access.

Request a free trial

Prestizia FAQs

  • When was Prestizia founded?

    Prestizia was founded in 2011.

  • Where is Prestizia headquartered?

    Prestizia is headquartered in Paris, France.

  • What is the size of Prestizia?

    Prestizia has 3 total employees.

  • What industry is Prestizia in?

    Prestizia’s primary industry is Biotechnology.

  • Is Prestizia a private or public company?

    Prestizia is a Private company.

  • What is Prestizia’s current revenue?

    The current revenue for Prestizia is .

  • Who are Prestizia’s investors?

    Holdings Incubatrices has invested in Prestizia.

  • When was Prestizia acquired?

    Prestizia was acquired on 27-Jun-2012.

  • Who acquired Prestizia?

    Prestizia was acquired by TheraDiag.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »